# Porcine Collagen Type XI (Sus scrofa domesticus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/porcine-collagen-type-xi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** COL11A1 porcine, Pig collagen type XI, Swine collagen type XI, Domestic pig collagen type XI, Type XI porcine collagen, Collagen XI from Sus scrofa domesticus

## Overview

Porcine Type XI collagen (COL11A1/COL11A2) is a fibrillar collagen that regulates collagen fibril diameter in cartilage and connective tissue through interactions with Type II and IX collagen networks. Unlike Type I porcine collagen, no peer-reviewed clinical evidence supports supplemental Type XI collagen for any health outcome in humans.

## Health Benefits

• No documented health benefits exist for porcine Type XI collagen as a supplement (research shows COL11A1 is studied only as a cancer biomarker)
• Type I porcine collagen shows pain reduction in musculoskeletal conditions (moderate evidence from clinical studies)
• Type I porcine collagen demonstrates tissue integration and biocompatibility in dental applications (moderate evidence)
• Type I porcine collagen improves nasolabial fold appearance in dermal filler applications (preliminary evidence)
• Type I porcine collagen may support tendon healing in proximal hamstring tendinopathy (preliminary evidence)

## Mechanism of Action

Type XI collagen is a heterotrimeric molecule composed of alpha1(XI), alpha2(XI), and alpha3(XI) chains encoded by COL11A1, COL11A2, and COL2A1 genes respectively, functioning primarily to nucleate and limit fibril diameter of Type II collagen fibrils in cartilaginous extracellular matrix. It binds aggrecan and other proteoglycans via its N-terminal domain, maintaining the structural integrity of the pericellular matrix in chondrocytes. Orally ingested Type XI collagen is hydrolyzed into dipeptides and tripeptides such as hydroxyproline-glycine in the gut, but no receptor-mediated mechanism has been identified linking these fragments to COL11A1-specific biological activity.

## Clinical Summary

No published randomized controlled trials, cohort studies, or pilot trials have investigated oral porcine Type XI collagen supplementation as a therapeutic intervention in humans. COL11A1 research is dominated by oncology studies identifying it as a stromal biomarker in pancreatic, ovarian, and colorectal cancers, with no translational supplement applications. In contrast, Type I porcine collagen hydrolysate (5–10 g/day) has demonstrated statistically significant reductions in joint pain scores (VAS) in small trials (n=30–100), but these findings cannot be extrapolated to Type XI. The overall evidence base for porcine Type XI collagen as a supplement is absent, making efficacy claims scientifically unsupported.

## Nutritional Profile

Porcine Collagen Type XI is a fibrillar collagen protein (~100% protein by dry weight) composed predominantly of three alpha chains: α1(XI), α2(XI), and α3(XI) (the α3 chain being identical to α1(II) of Type II collagen). Amino acid composition mirrors fibrillar collagens: glycine constitutes approximately 33% of total residues (every third position in the Gly-X-Y triplet repeat), proline and hydroxyproline together account for ~20-22% of residues (hydroxyproline ~9-11%), with additional contributions from alanine (~10%), glutamic acid (~5%), arginine (~5%), and leucine (~3%). Contains trace 4-hydroxyproline and hydroxylysine as post-translational modifications critical for triple-helix stabilization and cross-linking. Molecular weight of the trimeric collagen molecule is approximately 300 kDa (each alpha chain ~130-140 kDa). Micronutrient content is negligible in isolated form; no significant vitamins or minerals are intrinsic to the purified protein. No dietary fiber content. Bioavailability as an oral supplement is poorly characterized specifically for Type XI; by analogy with Type I/II collagens, enzymatic hydrolysis yields small peptides (di- and tripeptides, notably Pro-Hyp and Hyp-Gly) with estimated intestinal absorption of bioactive peptides at 20-30% of ingested dose. Unlike Type I collagen, Type XI is a quantitatively minor component of connective tissue (constituting <1-5% of total collagen in cartilage), and no specific bioactive peptide sequences unique to Type XI with confirmed physiological effects have been isolated or quantified in human studies. Caloric contribution estimated at ~4 kcal/g protein, consistent with standard protein macronutrient value.

## Dosage & Preparation

No dosage information exists for porcine Type XI collagen supplements as this product does not appear to exist commercially. Type I porcine collagen is used in clinical settings at varying doses depending on application (injectable forms, membranes, dermal fillers). Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

No dedicated safety studies exist for isolated porcine Type XI collagen supplementation, though porcine-derived collagen products are generally recognized as safe (GRAS) at typical doses of 5–15 g/day when free of contaminants. Individuals with pork or porcine product allergies face a meaningful risk of allergic reactions, including urticaria or anaphylaxis, due to retained porcine antigenic epitopes. Religious dietary restrictions (halal, kosher) prohibit consumption of porcine-derived ingredients, which is a critical labeling consideration. No known drug interactions have been documented, and pregnancy safety data are absent; pregnant individuals should avoid use due to insufficient evidence.

## Scientific Research

No clinical trials or meta-analyses exist for porcine Type XI collagen as a supplement. The research identifies COL11A1 primarily as a cancer-related biomarker associated with poor survival outcomes and chemoresistance. All documented clinical applications involve Type I porcine collagen in injectable or membrane forms.

## Historical & Cultural Context

No historical or traditional use of porcine Type XI collagen is documented. Porcine-derived Type I collagen has been used in medical applications since the development of biocompatible materials, but Type XI collagen has no established history as a therapeutic ingredient.

## Synergistic Combinations

Not applicable - product does not exist commercially

## Frequently Asked Questions

### What is porcine collagen Type XI and how is it different from Type I?

Porcine Type XI collagen is a minor fibrillar collagen encoded by COL11A1 and COL11A2, found predominantly in articular cartilage where it controls Type II collagen fibril diameter. Type I collagen, encoded by COL1A1 and COL1A2, is the most abundant collagen in skin, bone, and tendons and has extensive clinical evidence for wound healing and joint support—evidence that does not apply to Type XI.

### Are there any proven health benefits of taking porcine Type XI collagen?

No peer-reviewed clinical trials have demonstrated health benefits from supplementing with porcine Type XI collagen in humans. COL11A1 is primarily studied as a cancer-associated stromal biomarker in pancreatic and ovarian cancer, not as a therapeutic supplement target. Any product marketing porcine Type XI collagen for joint health or anti-aging benefits lacks direct clinical substantiation.

### Can people with pork allergies take porcine Type XI collagen supplements?

No—porcine collagen is derived from Sus scrofa domesticus (domestic pig) tissue, and individuals with pork or alpha-gal syndrome allergies risk cross-reactive allergic responses including hives, gastrointestinal distress, or anaphylaxis. Alpha-gal syndrome, triggered by the galactose-alpha-1,3-galactose epitope present in mammalian-derived products, is a particular concern with all porcine collagen types. Individuals with known pork allergies should use marine or bovine collagen alternatives under medical guidance.

### What does COL11A1 have to do with cancer?

COL11A1 is overexpressed in cancer-associated fibroblasts within the tumor stroma of pancreatic ductal adenocarcinoma, colorectal, and ovarian cancers, where it promotes epithelial-to-mesenchymal transition (EMT) and chemotherapy resistance via integrin-FAK signaling pathways. Its overexpression correlates with poor prognosis and reduced survival in multiple tumor types, making it a diagnostic biomarker and potential drug target—not a supplement ingredient. This research context is entirely unrelated to the use of Type XI collagen as a dietary supplement.

### What is the recommended dosage for porcine Type XI collagen supplements?

No established or clinically validated dosage exists for porcine Type XI collagen as a standalone supplement, as no human trials have been conducted. General porcine collagen hydrolysate products (predominantly Type I) are typically studied at 5–10 g per day in musculoskeletal trials, but these doses are not specific to or validated for Type XI. Until clinical trials are conducted targeting Type XI specifically, no evidence-based dosing recommendation can be made.

### Is porcine Type XI collagen actually effective for joint or cartilage health?

There is no clinical evidence supporting the use of porcine Type XI collagen for joint or cartilage health in humans. Most research on COL11A1 (the gene encoding Type XI collagen) focuses on its role as a cancer biomarker rather than its therapeutic benefits. If you are seeking collagen supplementation for musculoskeletal support, Type I porcine collagen has moderate clinical evidence for pain reduction, making it a more evidence-based choice.

### How is porcine Type XI collagen sourced and processed from pigs?

Porcine Type XI collagen is typically extracted from connective tissues, cartilage, or bone of domesticated pigs (Sus scrofa domesticus) and then processed through enzymatic digestion or acid hydrolysis to create soluble forms suitable for supplementation. The extraction method can affect molecular structure and bioavailability, though processing standards vary significantly between manufacturers. Most commercial sources do not distinguish between Type XI and other collagen types in final products, as Type XI is difficult to isolate in pure form.

### Why do supplement companies market Type XI collagen when there's no proven benefit?

Type XI collagen is marketed based on its structural role in cartilage and connective tissue, even though human clinical trials demonstrating supplemental benefits do not exist. Companies may capitalize on the ingredient's scientific name and biological function without distinguishing between basic research and proven supplemental efficacy. Consumers should be cautious of marketing claims for Type XI collagen specifically and verify whether clinical evidence supports the intended health outcome.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*